These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38568044)

  • 1. High Frequency of Cognitive and Behavioral Impairment in Amyotrophic Lateral Sclerosis Patients with SOD1 Pathogenic Variants.
    Calvo A; Moglia C; Canosa A; Manera U; Vasta R; Grassano M; Daviddi M; De Mattei F; Matteoni E; Gallone S; Brunetti M; Sbaiz L; Cabras S; Peotta L; Palumbo F; Iazzolino B; Mora G; Chiò A
    Ann Neurol; 2024 Jul; 96(1):150-158. PubMed ID: 38568044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive and Behavioral Features of Patients With Amyotrophic Lateral Sclerosis Who Are Carriers of the
    Moglia C; Calvo A; Canosa A; Manera U; Vasta R; Di Pede F; Daviddi M; Matteoni E; Brunetti M; Sbaiz L; Cabras S; Gallone S; Grassano M; Peotta L; Palumbo F; Mora G; Iazzolino B; Chio A
    Neurology; 2024 Feb; 102(4):e208082. PubMed ID: 38261982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and Cognitive Phenotypes of Patients With Amyotrophic Lateral Sclerosis Carrying SOD1 Variants.
    Dalla Bella E; Bersano E; Bruzzone MG; Gellera C; Pensato V; Lauria G; Consonni M
    Neurology; 2022 Oct; 99(18):e2052-e2062. PubMed ID: 35985819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel p.N66T mutation in exon 3 of the SOD1 gene: report of two families of ALS patients with early cognitive impairment.
    Martinelli I; Zucchi E; Gessani A; Fini N; Chiò A; Pecoraro V; Trenti T; Mandrioli J
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 May; 21(3-4):296-300. PubMed ID: 32248719
    [No Abstract]   [Full Text] [Related]  

  • 5. ALS phenotype is influenced by age, sex, and genetics: A population-based study.
    Chiò A; Moglia C; Canosa A; Manera U; D'Ovidio F; Vasta R; Grassano M; Brunetti M; Barberis M; Corrado L; D'Alfonso S; Iazzolino B; Peotta L; Sarnelli MF; Solara V; Zucchetti JP; De Marchi F; Mazzini L; Mora G; Calvo A
    Neurology; 2020 Feb; 94(8):e802-e810. PubMed ID: 31907290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment across ALS clinical stages in a population-based cohort.
    Chiò A; Moglia C; Canosa A; Manera U; Vasta R; Brunetti M; Barberis M; Corrado L; D'Alfonso S; Bersano E; Sarnelli MF; Solara V; Zucchetti JP; Peotta L; Iazzolino B; Mazzini L; Mora G; Calvo A
    Neurology; 2019 Sep; 93(10):e984-e994. PubMed ID: 31409738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis.
    Wicks P; Abrahams S; Papps B; Al-Chalabi A; Shaw CE; Leigh PN; Goldstein LH
    J Neurol; 2009 Feb; 256(2):234-41. PubMed ID: 19252762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the clinical and cognitive features of genetically positive ALS patients from the largest tertiary center in Serbia.
    Marjanović IV; Selak-Djokić B; Perić S; Janković M; Arsenijević V; Basta I; Lavrnić D; Stefanova E; Stević Z
    J Neurol; 2017 Jun; 264(6):1091-1098. PubMed ID: 28444446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High serum uric acid levels are protective against cognitive impairment in amyotrophic lateral sclerosis.
    Iazzolino B; Grassano M; Moglia C; Canosa A; Manera U; Vasta R; Cabras S; Callegaro S; Matteoni E; Di Pede F; Palumbo F; Mora G; Calvo A; Chiò A
    J Neurol; 2024 Feb; 271(2):955-961. PubMed ID: 37880536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy.
    Montuschi A; Iazzolino B; Calvo A; Moglia C; Lopiano L; Restagno G; Brunetti M; Ossola I; Lo Presti A; Cammarosano S; Canosa A; Chiò A
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):168-73. PubMed ID: 24769471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics screening in an Italian cohort of patients with Amyotrophic Lateral Sclerosis: the importance of early testing and its implication.
    Libonati L; Cambieri C; Colavito D; Moret F; D'Andrea E; Del Giudice E; Leon A; Inghilleri M; Ceccanti M
    J Neurol; 2024 Apr; 271(4):1921-1936. PubMed ID: 38112783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of C9orf72 hexanucleotide repeat expansion and SOD1 mutations in Portuguese patients with amyotrophic lateral sclerosis.
    Gromicho M; Pinto S; Gisca E; Pronto-Laborinho AC; Andersen PM; de Carvalho M
    Neurobiol Aging; 2018 Oct; 70():325.e7-325.e15. PubMed ID: 29861044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misfolded SOD1 inclusions in patients with mutations in
    Forsberg K; Graffmo K; Pakkenberg B; Weber M; Nielsen M; Marklund S; Brännström T; Andersen PM
    J Neurol Neurosurg Psychiatry; 2019 Aug; 90(8):861-869. PubMed ID: 30992335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment in amyotrophic lateral sclerosis, clues from the SOD1 mouse.
    Spalloni A; Longone P
    Neurosci Biobehav Rev; 2016 Jan; 60():12-25. PubMed ID: 26602023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognition and behaviour in frontotemporal dementia with and without amyotrophic lateral sclerosis.
    Saxon JA; Thompson JC; Harris JM; Richardson AM; Langheinrich T; Rollinson S; Pickering-Brown S; Chaouch A; Ealing J; Hamdalla H; Young CA; Blackburn D; Majeed T; Gall C; Jones M; Snowden JS
    J Neurol Neurosurg Psychiatry; 2020 Dec; 91(12):1304-1311. PubMed ID: 33055142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature.
    Giannoccaro MP; Bartoletti-Stella A; Piras S; Pession A; De Massis P; Oppi F; Stanzani-Maserati M; Pasini E; Baiardi S; Avoni P; Parchi P; Liguori R; Capellari S
    J Neurol; 2017 Jul; 264(7):1426-1433. PubMed ID: 28620717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study.
    Byrne S; Elamin M; Bede P; Shatunov A; Walsh C; Corr B; Heverin M; Jordan N; Kenna K; Lynch C; McLaughlin RL; Iyer PM; O'Brien C; Phukan J; Wynne B; Bokde AL; Bradley DG; Pender N; Al-Chalabi A; Hardiman O
    Lancet Neurol; 2012 Mar; 11(3):232-40. PubMed ID: 22305801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of cognitive impairment in Korean ALS patients without known genetic mutations.
    Oh SI; Park A; Kim HJ; Oh KW; Choi H; Kwon MJ; Ki CS; Kim HT; Kim SH
    PLoS One; 2014; 9(2):e87163. PubMed ID: 24498297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of APOE in the Occurrence of Frontotemporal Dementia in Amyotrophic Lateral Sclerosis.
    Chiò A; Brunetti M; Barberis M; Iazzolino B; Montuschi A; Ilardi A; Cammarosano S; Canosa A; Moglia C; Calvo A
    JAMA Neurol; 2016 Apr; 73(4):425-30. PubMed ID: 26903389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced mitochondrial D-loop methylation levels in sporadic amyotrophic lateral sclerosis.
    Stoccoro A; Smith AR; Mosca L; Marocchi A; Gerardi F; Lunetta C; Cereda C; Gagliardi S; Lunnon K; Migliore L; Coppedè F
    Clin Epigenetics; 2020 Sep; 12(1):137. PubMed ID: 32917270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.